AAAsuka Ashikari

Asuka Ashikari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asuka Ashikari has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gut microbiota-based prediction for the transition from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) in a remote island cohort study

    by Tsugumi Uema, Mari Tsukita, Shiki Okamoto, Moriyuki Uehara, Ken-Ichiro Honma, Yoshiro Nakayama, Atsuko Tamaki, Minoru Miyazato, Asuka Ashikari, Shiro Maeda, et al.

  • Influence of cerebral infarction on both bladder and urethral activities and changes after tramadol administration in rats

    by Satoko Nagamine, Tadanobu Chuyo Kamijo, Asuka Ashikari, Minoru Miyazato

    Aims: We investigated the changes in bladder and urethral function after cerebral infarction (CI) and the influence of tramadol on these functions.Methods: Twenty‐eight female Sprague Dawley rats were divided into normal and CI groups. In the awake condition, metabolic cage study and blood pressure were evaluated. Under urethane anesthesia, the intravenous effect of tramadol (0.01–1 mg/kg), which has both µ‐opioid receptor stimulation and inhibition of norepinephrine and serotonin reuptake, on continuous cystometry, and simultaneous measurements of bladder and urethral perfusion pressure (UPP) were recorded. Infarcted lesions were examined by staining with triphenyltetrazolium chloride, a marker of mitochondrial enzyme activity.Results: CI rats showed impaired sympathetic activity with Horner's syndrome and lower blood pressure. In metabolic cage study, urinary frequency during the dark phase was increased in CI rats. On bladder activity, in CI rats, the baseline pressure threshold for inducing bladder contractions was significantly lower (p < 0.01), and the intercontraction interval was prolonged after tramadol administration. On urethral activity, the baseline UPP was significantly lower in CI rats than in normal rats and it did not change after tramadol administration. Residual urine rate was significantly increased in normal rats, but not in CI rats. CI rats showed brain infarction including the cortex and hypothalamus, which is a center of the autonomic nervous system.Conclusions: CI‐induced ischemic brain damage results in impairment of both bladder and urethral functions, in addition to decreased sympathetic activity. Bladder overactivity after CI can be improved by tramadol; however, urethral activity cannot be improved by it.


  • Open Access

    Obesity and Voiding Parameters in a Community-Based Population of Okinawa, Japan: Kumejima Digital Health Project (KDHP)

    by Asuka Ashikari, Minoru Miyazato, Koshi Nakamura, Kiyoto Yamashiro, Takehiro Nakamura, Tsugumi Uema, Moriyuki Uehara, Hiroaki Masuzaki, Seiichi Saito, Shiro Maeda, et al.

    (1) Background: Evidence has accumulated regarding the etiology of lower urinary tract symptoms associated with obesity and metabolic syndrome. Therefore, the present study aimed to identify which subjectively and objectively measured voiding parameters were associated with obesity in a community-based population. (2) Methods: Voiding parameters on a self-administered questionnaire and a digital self-health monitoring system for urine excretion (s-HMSU) were compared between participants with and without obesity, defined as a body mass index ≥ 25 kg/m2 (n = 30 and 29, respectively), from a community in Okinawa, Japan. Logistic regression analysis was employed to calculate the odds ratios of abnormalities in voiding parameters for the obese group, with the non-obese group serving as a reference. (3) Results: The obese group had odds ratios of 5.17 (95% confidence interval: 1.33–20.0) for shortened hours of undisturbed sleep (<302 min) by s-HMSU and 7.65 (1.88–31.1) for nighttime urinary frequency by a questionnaire after adjusting for age and sex. In addition, the obese group had an adjusted odds ratio of 2.27 (0.76–6.78) for decreased maximum bladder capacity (<212 mL) by s-HMSU. (4) Conclusion: the results of the present study suggest that nocturia and shortened hours of undisturbed sleep are signs of obesity.


  • Open Access

    Effect of a mobile digital intervention to enhance physical activity in individuals with metabolic disorders on voiding patterns measured by 24-h voided volume monitoring system: Kumejima Digital Health Project (KDHP)

    by Minoru Miyazato, Asuka Ashikari, Koshi Nakamura, Takehiro Nakamura, Kiyoto Yamashiro, Tsugumi Uema, Moriyuki Uehara, Hiroaki Masuzaki, Seiichi Saito, Shiro Maeda, et al.

    Purpose: To evaluate the effect of a mobile digital intervention on voiding patterns, we performed 24-h voided volume monitoring in individuals with metabolic disorders. Methods: Participants with metabolic disorders were grouped into either the intervention group (n = 17), who had access to a smartphone app (CARADA), or the non-intervention group (n = 11), who did not. Urine monitoring was conducted for 24 h using a novel digital self-health monitoring system for urine excretion (s-HMSU). Body weight, abdominal circumference, blood pressure, and biomarkers were measured. Results: Physical findings and blood test results at baseline and 6 months indicated no significant between-group differences. Night-time frequency did not change between baseline and 6 months in the intervention group but significantly worsened at 6 months in the non-intervention group, as compared to baseline (1.0 ± 0.7 vs. 1.5 ± 0.5, p < 0.05). The change in night-time frequency over 6 months did not differ between the intervention and non-intervention groups. Furthermore, the change in hours of undisturbed sleep over 6 months did not differ between the two groups. However, compared with baseline, nocturnal polyuria index tended to worsen at 6 months in the non-intervention group. Conclusion: Our study results suggest that mobile digital intervention might be useful for behavioral therapy to improve night-time frequency and urine production and that s-HMSU might be beneficial for confirming the prevention of progress in individuals with metabolic disorders, which can aid in modifying lifestyle.


  • Open Access

    Therapeutic new targets for stress urinary incontinence in the central nervous system

    by Minoru Miyazato, Asuka Ashikari

    腹圧性尿失禁(SUI)は,中年女性にみられる一般的疾患で,生活の質を著しく損なう.一方で,臨床的に,あまり有効な薬剤はない.妊娠,出産に伴う女性特有の成因に起因し,尿道過可動と内因性括約筋不全の二つに大別される.腹圧尿失禁の病態,創薬開発にあたって,直接的,間接的陰部神経損傷モデルが使用されている.私達は以前,脳梗塞ラットも尿禁制反射が減弱していることを報告した.SUI評価法として,リークポイント圧測定や尿道マイクロチップ法があり,私たちは後者にくしゃみ刺激を利用する独自の評価方法を確立した.実際,中枢にはSUIの標的が数多く存在することが明らかとなってきている.特に,ノルエピネフリン,セロトニン(5-HT)が標的で,陰部神経核(オヌフ核)周囲に存在するα1受容体,5-HT2C,5-HT7が尿禁制反射を増強,α2,5-HT1Aが減弱することが明らかとなっている.さらに,脊髄オピオイドμ受容体が尿禁制反射を増強することを,弱オピオイドであるトラマドールを用いて報告した.このように,脊髄にはSUIの新たな創薬開発の標的となる受容体が数多く存在する.


  • PO-0688 IMPACT OF RADIATION DOSE ON INTERMEDIATE-RISK PROSTATE CANCER PATIENTS TREATED WITH BRACHYTHERAPY ALONE OR BOOST

    by A. Yorozu, K. Toya, S. Saito, T. Nishiyama, K. Yoshida, N. Koike, A. Takahashi, Y. Yagi, R. Namidome, A. Ashikari

  • PO-162 IMPACT OF DOSE ON INTERMEDIATE-RISK PROSTATE CANCER PATIENTS TREATED WITH BRACHYTHERAPY ALONE OR BOOST

    by A. Yorozu, K. Toya, K. Yoshida, N. Koike, A. Takahashi, S. Saito, T. Nishiyama, Y. Yagi, R. Namidome, A. Ashikari